BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News
Alzheon Announces Notice Of Allowance For U.S. Patent For Its Lead Drug Candidate ALZ-801 In Clinical Development For Alzheimer’s Disease 4/15/2014  More...
Japan Patent Office Issues Advaxis, Inc. A Notice Of Allowance For Two Patent Applications Covering Its Cancer Immunotherapy Platform Technology 4/14/2014  More...
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014  More...
American CryoStem Corporation And Rutgers University File Joint Patent On Adipose-Derived Stem Cell Platform Technology 4/10/2014  More...
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Hong Kong For Oral Administration Of Insulin 4/10/2014  More...
BrainStorm Cell Therapeutics Inc. Granted Additional US Patent For Its Autologous Stem Cell Technology 4/10/2014  More...
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued An Additional Notice Of Allowance With Claims Covering RAYOS® (Prednisone) Delayed-Release Tablets 4/10/2014  More...
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In Canada And Hong Kong 4/10/2014  More...
Epizyme (EPZM) Granted Patent Covering Diagnosis And Treatment Of Cancers Associated With EZH2 Mutation 4/8/2014  More...
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014  More...
Alnylam Pharmaceuticals (ALNY)’s McSwiggen Patent Upheld in European Opposition Proceedings 4/7/2014  More...
USPTO Grants A New Inhaler Patent To Hovione 4/7/2014  More...
United States PTO Rejects Teva's '808 Patent Reissue Application On Copaxone® For The Second Time 4/4/2014  More...
AnaptysBio, Inc. Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology 4/3/2014  More...
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014  More...
Mersana Therapeutics, Inc. Awarded Patent With Broad Coverage For Fleximer-ADC Platform Technology 4/2/2014  More...
IntelliCell BioSciences (SVFC) Has Received Its Hong Kong Patent Application Notice For ULTRASONIC CAVITATION 4/2/2014  More...
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent And Trademark Office For Three Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy Platform Technology 4/1/2014  More...
Enzymotec Provides Update On Patent Litigation With Neptune Technologies & Bioressources Inc. 4/1/2014  More...
Eagle Pharmaceuticals (EGRX)’ Exclusive Licensor Granted U.S. Patent For Dantrolene In The Treatment Of Heat Stroke 4/1/2014  More...
The Medicines Company (MDCO) Release: Update On Angiomax® (Bivalirudin) Patent Litigation 4/1/2014  More...
Integral Molecular, Inc. Announces Patent Protecting The Use Of Lipoparticles For Antibody Discovery 3/31/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent 3/31/2014  More...
iBio, Inc. (IBIO) Receives Patent Allowances For Pandemic Influenza Therapeutics 3/27/2014  More...
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In U.S.A. 3/26/2014  More...
ProLynx Issues U.S. Patent Covering Beta-Eliminative Linkers 3/26/2014  More...
Iroko Pharmaceuticals Announces Key Patent Grant For ZORVOLEX™ 3/25/2014  More...
Moberg Pharma AB (Formerly known as Moberg Derma) Launches New Patent Pending Formulation Of Kerasal Nail In The U.S. 3/24/2014  More...
BrainStorm Cell Therapeutics Inc. Granted Key US Patent For Its Autologous Stem Cell Technology 3/24/2014  More...
Merck & Co., Inc. (MRK) HIV Drug Strategy Seen Shielding Patent 3/21/2014  More...
MultiCell Technologies Inc. (MCET.OB) Files U.S. And International Patent Applications For The Treatment Of Liver Cancer 3/21/2014  More...
Actavis (ACT) Announces Daytrana® Patent Challenge Settlement 3/20/2014  More...
TapImmune Inc. (TPIV) Is Pleased To Announce The Filing Of New Intellectual Property Surrounding Its Novel And Proprietary Platform Expression System Polystart™ 3/20/2014  More...
Collegium Pharmaceutical, Inc. Announces Allowance Of New Claims Covering DETERx®, An Abuse-Deterrent, Extended-Release, Technology Platform 3/19/2014  More...
Advaxis, Inc. Receives Patent In Japan For ADXS-HPV For The Treatment Of Cervical Cancer 3/18/2014  More...
BioLineRx Ltd. Announces Issuance Of United States Patent Covering Use Of BL-8040 In Immunotherapy 3/14/2014  More...
Idenix Pharmaceuticals, Inc. (IDIX) Files Patent Infringement Lawsuits Against Gilead Sciences, Inc. (GILD) In Europe 3/14/2014  More...
Pfizer Inc. (PFE) Faces Earlier Celebrex Competition After Ruling, Vows To Appeal 3/13/2014  More...
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Third US Patent Protecting Trokendi XR™ 3/12/2014  More...
XBiotech USA, Inc. Issued Patent For Antibody Therapy To Treat Chronic Sterile Inflammatory Diseases 3/12/2014  More...
TNI BioTech Granted Additional Patent For Methods For Inducing Sustained Immune Response Of T-Cells 3/12/2014  More...
Elite Pharmaceuticals, Inc. (ELI) Expands Abuse Deterrent Technology Patent Portfolio Internationally 3/10/2014  More...
Ensysce Biosciences Inc. Receives Notice Of Allowance For U.S. Patent For Delivery Of siRNA 3/7/2014  More...
RXi Pharmaceuticals (RXII) Granted Key Patent Related To Self-Delivering Technology For The Treatment Of Fibrotic Disorders 3/5/2014  More...
Generex Biotechnology Corporation (GNBT) Subsidiary Antigen Express Receives Patents For Vaccines Targeting HPV Induced Cancers And Influenza 3/5/2014  More...
Synageva BioPharma (GEVA) Issued U.S. Patent For Treatment Of LAL Deficiency 3/4/2014  More...
Braasch Biotech Bolsters Intellectual Property With Patent Acceptances In Australia And Japan 3/4/2014  More...
Settlement Between BioPorto And Phadia AB In Patent Case 3/3/2014  More...
Fibrotech Is Granted U.S. And Canadian Patents For Its Anti-Fibrotic Compounds 3/3/2014  More...
Galena Biopharma  (GALE) Bolsters Neuvax™ (Nelipepimut-S) Intellectual Property With Patent Acceptance In Australia 2/28/2014  More...
Actavis (ACT) Confirms Generic Colcrys® Patent Challenge 2/28/2014  More...
Immunomedics, Inc. (IMMU) Extends Patent Life On Therapeutic Antibodies 2/27/2014  More...
IntelGenx Corp. Announces Receipt Of Two Additional U.S. Patent Allowances Related To Proprietary Technology 2/26/2014  More...
Galectin Therapeutics Secures U.S. Patent For Its Proprietary Galectin Inhibitor GR-MD-02 In Fatty Liver Disease 2/26/2014  More...
Theranostics Health Announces Issuance Of U.S. Patent 8,628,931 B2: mTOR Pathway Theranostic 2/26/2014  More...
Meditope Biosciences Announces Issuance of New Patent 2/26/2014  More...
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014  More...
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014  More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treatment Of Dry Eye Syndrome 2/24/2014  More...
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014  More...
Rockwell Medical (RMTI) Receives Japanese Patent Issuance For Triferic™ GMP Formulation 2/21/2014  More...
La Jolla Pharmaceutical Company (LJPC) Receives Notice Of Allowance For Patent Claims Covering Modified Pectin For Treatment Of Chronic Inflammation 2/20/2014  More...
Scancell: Publication Of Moditope Patent 2/18/2014  More...
Pluristem Therapeutics (PSTI) Receives Key 3D Cell Expansion Patent In Australia 2/18/2014  More...
BioAlliance Pharma: Strengthening And Extension Of The Industrial Protection Of Livatag® Until 2031 2/18/2014  More...
Mapi Pharma Granted United States Patent Covering The Process For The Preparation Of Fingolimod For Multiple Sclerosis 2/18/2014  More...
Altos Therapeutics Receives Allowance For Issue Of United States Patent 2/13/2014  More...
OvaScience (OVAS) Issued Two U.S. Patents Covering AUGMENT? Fertility Treatment 2/12/2014  More...
Regado Biosciences, Inc. (RGDO) Broadens Patent Family Protecting Core Technology 2/12/2014  More...
Avaxia Biologics, Inc. Awarded Patent With Broad Coverage Over Oral Anti-TNF Antibodies For Inflammatory Bowel Disease 2/11/2014  More...
Ironwood Pharmaceuticals (IRWD) Receives Notice Of Allowance For Methods Of Use Formulation Patent Expected To Extend LINZESS® Patent Protection Through 2031 2/10/2014  More...
Coronado Biosciences (CNDO) Granted A Second Key Patent For CNDO-109, An Activator Of Natural Killer Cells 2/6/2014  More...
Immunomedics, Inc. (IMMU) Ranks 4th In The Patent Board Biotechnology Industry Scorecard 2/5/2014  More...
Aegis Therapeutics, LLC Awarded Its First Patent For Oral Delivery Of Nucleotide-Based Drugs With High Bioavailability 2/5/2014  More...
U.S. Patent Institutions Recognize The Patentability Of Institut Pasteur/Cellectis Early Inventions On Meganucleases 2/5/2014  More...
U.S. Patent & Trademark Office (USPTO) Issues Patent To Elorac, Inc. For Novel Acne Therapy 2/5/2014  More...
Salix Pharmaceuticals, Ltd. (SLXP) Announces Issuance Of U. S. Patent For Rifaximin 2/4/2014  More...
Verastem, Inc. (VSTM) Issued Japanese Patent On Dual mTORC1/2 And PI3K Inhibitor VS-5584 2/4/2014  More...
Arcadia Biosciences, Inc. Receives U.S. Patent For Nitrogen Use Efficiency Technology In Monocot Crops 2/4/2014  More...
Actavis (ACT) Confirms Generic Treanda® Patent Challenge 2/4/2014  More...
BrainStorm Cell Therapeutics Inc. Receives US Notice Of Allowance For Its Key Stem Cell Technology Patent 2/3/2014  More...
OncoMed Pharmaceuticals, Inc. (OMED) Granted Fourth RSPO-LGR Pathway Patent In U.S. 2/3/2014  More...
Enzymotec Announces It Has Been Granted Patents For INFAT®'S Uses In Canada And The US 2/3/2014  More...
Suven Life Sciences Ltd Product Patents For Their NCEs In Canada, China And India 1/31/2014  More...
AMAG Pharmaceuticals, Inc. (AMAG) Announces Issuance Of New U.S. Patent For Ferumoxytol 1/31/2014  More...
BioLife Solutions, Inc. (BLFS.OB) To Be Issued New Biopreservation Patent 1/30/2014  More...
Idenix Pharmaceuticals, Inc. (IDIX) Announces Decision By The United States Patent And Trademark Office Patent Trial And Appeal Board In The First Patent Interference 1/30/2014  More...
Altheus Therapeutics Announces The USPTO Has Awarded The Zoenasa Patent For Oral Combination Therapy 1/30/2014  More...
Pivotal Therapeutics Inc. Announces Notice Of Allowance For U.S. Patent On Its Unique 6:1 EPA:DHA Formulation 1/30/2014  More...
NeuroNascent, Inc. Announces Issuance Of US Patent Covering Second-Generation Neurorestorative Therapeutic Candidate 1/29/2014  More...
Depomed, Inc. (DEPO) Announces Favorable Markman Ruling In GRALISE® Patent Litigation 1/29/2014  More...
Supernus Pharmaceuticals (SUPN) Announces Issuance Of First Use Patents Protecting SPN-812 As A Novel Non-Stimulant ADHD Product 1/27/2014  More...
Marina Biotech, Inc. (MRNA) Achieves Broad Patent Coverage For DiLA2 Nucleic Acid Delivery Technology In U.S., Europe And Japan 1/24/2014  More...
Royal DSM Wins Patent Opposition Appeal Impacting Stereolithography Development 1/24/2014  More...
Adamis Pharmaceuticals Receives Notice Of Key Allowance For US Patent That Supports Its Cancer Immunology Portfolio 1/24/2014  More...
Microbix Biosystems Inc. (MBXBF) Wins VIRUSMAX® Patent Challenge In Europe 1/23/2014  More...
Lpath, Inc. Granted Key U.S. Patent Related To Ocular Drug Program, iSONEP 1/23/2014  More...
Alitair Pharmaceuticals Announces Issuance Of An Additional Patent Covering Its Platform Drug Delivery Technology, REA™ 1/22/2014  More...
iBio, Inc. (IBIO) Receives Allowance Of Patent For HPV-Related Cancer Vaccine In China 1/21/2014  More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Allowance From U.S. Patent Office For Treatment And Prevention Of Neuro And Muscular Degenerative Diseases 1/16/2014  More...
MultiCell Technologies Inc. (MCET.OB) Files Patent Application Covering New Class Of RNA Therapeutics 1/15/2014  More...
Marina Biotech, Inc. (MRNA) Strengthens The Intellectual Property Estate For The Transkingdom RNA Interference Nucleic Acid Delivery Technology 1/15/2014  More...
Anergis Obtains Core Technology Patent In Japan 1/14/2014  More...
Mirna Therapeutics, Inc. Reports Expansion Of Intellectual Property Estate 1/14/2014  More...
RXi Pharmaceuticals (RXII) Receives US Notice Of Allowance For A Key Patent Relating To Its Self-Delivering Technology With Sd-Rxrnas Targeting CTGF, Including RXI-109, For The Treatment Of Fibrotic Disorders 1/14/2014  More...
Fuisz Pharma Announces Patent Filing For Novel System And Method To Obtain Blood For Diagnostic Analysis Using A Lancet Or Needle Puncture 1/14/2014  More...
Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio 1/13/2014  More...
BrainStorm Cell Therapeutics Inc. Receives United States Patent Office Notice Of Allowance For Its Stem Cell Technology 1/13/2014  More...
Forest Laboratories, Inc. (FRX) Pursues Additional Market Exclusivity To Extend Namenda Patent 1/13/2014  More...
Neogen Corporation (NEOG) Licenses Cargill Patents 1/13/2014  More...
Marina Biotech, Inc. (MRNA) Strengthens the Intellectual Property Estate For SMARTICLES® Nucleic Acid Delivery Technology 1/10/2014  More...
CorMedix (CRMD) Awarded European Patent For Neutrolin 1/10/2014  More...
Athersys, Inc. Announces New Patents In Japan For Stem Cell And Regenerative Medicine Technology 1/9/2014  More...
Suven Life Sciences Ltd Three (3) Product Patents For Their Nces In Australia, Sri Lanka And South Korea 1/9/2014  More...
Pluristem Therapeutics (PSTI) Receives Key Placental Cell Therapy Patent in Australia 1/8/2014  More...
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance To Grant European Patent Covering Its Stem Cells For The Treatment Of CNS Diseases 1/8/2014  More...
Veloxis Pharmaceuticals A/S (VELO) Receives Notice Of Allowance From U.S. Patent Office For Diurnal-Independent Administration Of Envarsus® 1/8/2014  More...
Aphios Granted United States Patent For Pretreating Cellulosic Biomass To Manufacture Biofuels And Biochemicals 1/8/2014  More...
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Third US Patent Protecting Oxtellar XR® 1/7/2014  More...
Galectin Therapeutics Receives US Patent For Combination Treatment For Liver Fibrosis 1/6/2014  More...
Enzymotec Granted Patent For A Lipid Preparation Use Method 1/6/2014  More...
Alkermes plc (ALKS) Announces Notice Of Allowance Of U.S. Patent For A Novel Fumarate Prodrug For Multiple Sclerosis 1/6/2014  More...
Eli Lilly and Company (LLY) Faces Financial Difficulty Over Loss Of Cymbalta Patent 1/3/2014  More...
Oramed Pharmaceuticals Inc. (ORMP) Receives Patent Allowance In Israel And Australia For Platform Technology In Oral Delivery Of Proteins 1/2/2014  More...
Immunomedics, Inc. (IMMU) Announces U.S. Patent For Antibody-SN-38 Conjugates 12/31/2013  More...
Actavis (ACT) Confirms Generic NuvaRing® Patent Challenge 12/27/2013  More...
Antares Pharma, Inc. (AIS) Announces Notice Of Allowance For New Patent On Reconstitutable Lyophilized Injectables 12/20/2013  More...
ERYtech Pharma Announces The Decision Of USPTO To Extend The Additional Exclusivity Period Of Its Core Process Patent To Almost 4 Years 12/20/2013  More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Allowance From Canadian Patent Office For Reversal Of Skin Aging 12/20/2013  More...
Aastrom Biosciences, Inc. (ASTM) Granted Composition-Of-Matter Patent For Ixmyelocel-T In Australia 12/19/2013  More...
Acorda Therapeutics (ACOR) Announces European Patent Office Upholds Fampridine (FAMPYRA®) Patent 12/19/2013  More...
Keryx Biopharmaceuticals (KERX) Announces Issuance Of U.S. Patent For Zerenex™ Covering Orally Administrable Forms Of Ferric Citrate 12/18/2013  More...
Absorption Systems Awarded Japanese Patent For CellPort Technologies® 12/17/2013  More...
Caris Life Sciences Receives Patent For Molecular Profiling Service In The People's Republic Of China 12/17/2013  More...
Biousian BioSystems Receives U.S. Patent For Best-In-Class Analgesic 12/16/2013  More...
Expanse Bioinformatics Receives New Patent 12/13/2013  More...
Scancell's DNA ImmunoBody® Patent Granted In Japan 12/12/2013  More...
AB Biosciences' Key Recombinant Control Antibody Patent Issued 12/12/2013  More...
GW Pharmaceuticals Announces U.S. Patent Allowance For Use Of Cannabinoids In Treating Glioma 12/11/2013  More...
Rexahn Pharmaceuticals, Inc. (RNN) Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin™ (RX-5902) 12/11/2013  More...
Plandai Biotechnology, Inc. (PLPL.OB) Announces Intellectual Property Filings 12/11/2013  More...
Idenix Pharmaceuticals, Inc. (IDIX) Announces Declaration Of Senior Party In A Second Patent Interference By The USPTO 12/9/2013  More...
TherapeuticsMD, Inc.  (TXMD) Receives Notice Of Allowance For Patent Covering Platform Technology Of Oral Combination Bioidentical 17ß-Estradiol And Progesterone 12/9/2013  More...
Stellar Biotechnologies, Inc. Announces Patents For Clostridium Difficile Immunotherapy Technology Issued In U.S. And China 12/9/2013  More...
KaloBios Pharmaceuticals, Inc. Receives Notice Of Allowance For Key Composition Of Matter Patent Covering KBOO4 12/6/2013  More...
Aeolus Pharmaceuticals Inc. (AOLS.OB) Files Application For New Patent On AEOL 10150 12/5/2013  More...
MorphoSys AG Strengthens European Patent Position On Anti-CD19 Cancer Program MOR208 12/3/2013  More...
IMPAX Laboratories, Inc. (IPXL) Announces OxyContin® Patent Challenge Settlement 12/3/2013  More...
Amarin Corporation PLC (AMRN) Announces Notification Of Patent Allowances For U.S. Applications 13/685,281, And 13/685,291 Related To Triglyceride Lowering With A Mixture Of Omega-3 Free Fatty Acid (Including EPA And/Or DHA) In Both The MARINE And ANCHOR Patient Populations 12/2/2013  More...
Antares Pharma, Inc. (AIS) Announces Additional U.S. Patent Protection For OTREXUP™ 11/26/2013  More...
Omni Bio Pharmaceutical Announces Notice Of Allowance For New Use Patent 11/26/2013  More...
Parcell Laboratories Release: New Stem Cell Platform Technology Recognized With Patent Award 11/26/2013  More...
TopoTarget A/S Release: Allowance Of Key Belinostat Patent In Europe 11/21/2013  More...
XOMA (US) LLC (XOMA) Awarded Key Flexible Manufacturing Patent 11/20/2013  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Receives Patent In The European Union For the Oral Delivery of Insulin 11/19/2013  More...
BioLargo, Inc. (BLGO.PK) Granted Additional Patent As It Lands Second Order From US Government 11/18/2013  More...
Plasticell Release: Additional Family Of CombiCult® Patents Granted In USA, Europe, Australia And Singapore 11/18/2013  More...
Navidea Biopharmaceuticals (NAVB) Announces Issuance Of New U.S. Patent Covering Formulation For Neuroimaging Agent, NAV5001 11/14/2013  More...
BioAlliance Pharma Strengthens Sitavig Patent Protection With New U.S. And South Korean Issued Patents 11/14/2013  More...
Actavis (ACT) Confirms Generic Axiron® Patent Challenge 11/14/2013  More...
Intellect Neurosciences, Inc. Obtains Patent Allowance From The United States Patent And Trademark Office In Relation To Its TOC-1 Monoclonal Antibody Selective For Pre-Fibrillar Tau Aggregates 11/14/2013  More...
Zysis Receives U.S. Patent for Long Acting Oral Aripiprazole Once Weekly 11/13/2013  More...
Ohr Pharmaceutical (OHRP) Receives Canadian Patent For Squalamine 11/13/2013  More...
VIVUS, Inc. (VVUS) Announces Issuance Of Two Key U.S. Patents For Qsymia; Patent Coverage For Qsymia Extended To 2029 11/13/2013  More...
MultiCell Technologies Inc. (MCET.OB) Files U.S. Patent Application For Targeted Delivery Of MCT-485, A Noncoding miRNA For Cancer Treatment 11/13/2013  More...
Palatin Technologies (PTN) Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents 11/12/2013  More...
MediciNova, Inc. Receives New Patent Covering MN-221 In Irritable Bowel Syndrome 11/12/2013  More...
BioInvent (BOVNF) Granted US Patent for the F.I.R.S.T.™ Antibody Screening Technology 11/11/2013  More...
Civitas Therapeutics Extends CVT-301 Patent Protection Into 2032 11/8/2013  More...
New U.S. Patent Issued to Dyadic International, Inc. 11/8/2013  More...
Integral Molecular, Inc. Announces Issuance of Third Patent Family, Extending Patent Landscape for Key Lipoparticle Technology 11/7/2013  More...
Rosetta Genomics Ltd. (ROSG) Granted U.S. Patent Allowance for the Use of microRNAs to Treat Liver Cancer 11/7/2013  More...
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their NCEs in U.S.A. and Japan 11/6/2013  More...
Omni Bio Pharmaceutical Announces U.S. Patent Action for Its Recombinant Alpha-1 Antitrypsin Molecule 11/6/2013  More...
Can-Fite BioPharma (CFBI) Release: U.S. Patent and Trademark Office Grants a Patent for the Reduction of Intraocular Pressure 11/6/2013  More...
Bacterin International, Inc. Awarded Patent for Method to Produce Demineralized Bone Matrix 11/6/2013  More...
ImmunoGen, Inc. (IMGN) Awarded Key Patent for TROP-2 Antibody 11/5/2013  More...
The Jackson Laboratory Awarded Second U.S. Patent for "Freezing" Cumulative Genetic Drift in Mice 11/5/2013  More...
Transposagen Biopharmaceuticals, Inc. Issued Two Key U.S. Patents 11/4/2013  More...
Aphios Granted United States Patent for Oral Delivery of Cannabinoids Such as ?9-THC in Nanoparticles 11/4/2013  More...
The Jackson Laboratory Awarded Japanese Patent on Process to Effectively "Freeze" Cumulative Genetic Drift in Mice 11/1/2013  More...
U.S. Patent Office Issues Patent for VG Life Sciences, Inc. (VGLS)' Peptide for HIV Treatment 10/31/2013  More...
Synta Pharmaceuticals (SNTA) Announces Publication of First Patent Application Covering Its Hsp90-inhibitor Drug Conjugate (HDC) Platform 10/31/2013  More...
Enzymotec Granted Patent for Its Composition of Vayacog® Addressing Memory and Mild Cognitive Impairment 10/30/2013  More...
D-Pharm Ltd. Granted Patent in US and China for its Phase 2 Product THR-18 10/30/2013  More...
Hope Pharmaceuticals Receives U.S. Patent for Medications Containing Sodium Nitrite 10/30/2013  More...
Sanovas Awarded Patent for Extravasated Drug Delivery 10/29/2013  More...
Drawbridge Pharmaceuticals Granted New Anaesthesia Patents for Phaxan™ 10/28/2013  More...
Antares Pharma, Inc. (AIS) Announces the Issuance of a New U.S. Patent on the VIBEX® Device Platform 10/25/2013  More...
IMPAX Laboratories, Inc. (IPXL) Confirms Patent Challenge Relating to Generic Atelvia® Delayed-Release Tablets, 35 mg 10/25/2013  More...
Immunicum's Patent Application Regarding the Company’s Core-Technology for Therapeutic Cancer Vaccination Using Allogeneic Dendritic Cells is Being Approved in the U.S. 10/25/2013  More...
Provectus Pharmaceuticals Inc. Awarded PV-10 Patent by U.S. Patent and Trademark Office 10/24/2013  More...
Merus Granted European Patent on MeMo®, a Transgenic Mouse for Generating the Building Blocks of Therapeutic Human Bispecific Antibodies 10/23/2013  More...
Immunomedics, Inc. (IMMU) Develops Dendritic-Cell Vaccine Technology for Lymphomas and Leukemias 10/23/2013  More...
La Jolla Pharmaceutical Company (LJPC) Receives Notice of Allowance of Patent Covering Modified Pectin Compositions 10/21/2013  More...
AnaptysBio, Inc. Receives Allowance of US Patent Covering Proprietary ABELmAb™ Libraries 10/17/2013  More...
Collegium Pharmaceutical, Inc. Announces Issuance of U.S. Patent and Allowance of New Claims Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product 10/17/2013  More...
Adaptive Biotechnologies Receives Critical Intellectual Property for Next Generation Immunosequencing Field 10/17/2013  More...
AltheRx is Granted U.S. Patent for Use of Solabegron in Combination With Antimuscarinics for the Treatment of Overactive Bladder 10/17/2013  More...
Fuisz Pharma Announces Allowance of Patent Claims by the Israeli Patent Office Relating to the Programming of Bodily Fluid Analyzers 10/16/2013  More...